Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 7/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 3/20 | 0.45 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.44 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3937776 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3939473 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3929242 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3936777 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3939841 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3929753 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3930451 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL3936778 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL2678812 | 0.85 | SIRT2 (0.51) | SIRT2SIRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL10800241 | 0.82 | MEN1 (0.52) | SIRT2SIRT1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116056721-A | Adjuvants with TLR4 agonist activity | 住友制药株式会社 | 2023-05-02 | — | — | CN | disclosed |